AbCellera Biologics Inc. (ABCL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -33.52M | -34.74M | -52.59M | -32.4M | -11.55M | -8M | -29M | -29.46M | -41.71M | -19.61M | -106K | 19.82M |
| Operating CF Margin % | -403.16% | -77.46% | -587.31% | -189.67% | -272.82% | -158.42% | -445.63% | -402.28% | -419.01% | -213.65% | -1.61% | 197.07% |
| Operating CF Growth % | -190.14% | -334.29% | -81.37% | -10% | 72.3% | 59.21% | -27256.05% | -248.65% | 5.34% | -163.44% | 99.92% | -92.7% |
| Net Income | -43.16M | -8.95M | -57.12M | -34.73M | -45.62M | -34.21M | -51.11M | -36.93M | -40.61M | -47.15M | -28.61M | -30.53M |
| Depreciation & Amortization | 8.65M | 8.99M | 7.24M | 7.06M | 6.61M | -18.1M | 38.3M | 38.04M | 6.77M | 9.11M | 7.41M | 7.26M |
| Stock-Based Compensation | 0 | 12.9M | 13.89M | 14.21M | 14.79M | 15.23M | 0 | 0 | 17.41M | 16.45M | 15.86M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.96M | 0 | 0 |
| Other Non-Cash Items | 14.39M | -1.7M | 1.53M | -2.14M | 2.21M | 45M | -10.37M | -22.78M | 1.71M | -1.39M | -1.93M | 15.5M |
| Working Capital Changes | -13.4M | -45.99M | -18.14M | -16.8M | 10.46M | -15.91M | -5.82M | -7.79M | -26.98M | 1.41M | 7.16M | 27.59M |
| Change in Receivables | 13.1M | -39.54M | 4.16M | -18.98M | -1.13M | -20.86M | -19.86M | -15.61M | -18.58M | -10.44M | -11.21M | -32.24M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.77M | 0 | 0 |
| Change in Payables | -9.41M | 5.79M | 5.07M | -3.95M | -3.41M | 0 | 4.13M | 4.75M | -4.88M | -13.25M | 975K | 2.94M |
| Cash from Investing | -25.08M | 75.14M | 36.49M | -31.81M | 7.93M | 35.7M | 3.94M | 51.52M | 29.91M | -24.32M | -12.79M | -35.04M |
| Capital Expenditures | -3.83M | -9.84M | -8.93M | -13.37M | -10.64M | -15.63M | -18.58M | -19.8M | -24.14M | -14.43M | -20.33M | -27.35M |
| CapEx % of Revenue | 46.07% | 21.95% | 99.7% | 78.23% | 251.15% | 309.5% | 285.61% | 270.34% | 242.52% | 157.22% | 308.09% | 271.98% |
| Acquisitions | 0 | -2.55M | -2.45M | -2.55M | 0 | 0 | 0 | 0 | -5.91M | -3.48M | -3.54M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 1.36M | 93.64M | 918K | 5.43M | 183.56M | 51.33M | 9.43M | 12.44M | 7.17M | 10.29M | 7.33M | 5.03M |
| Cash from Financing | 7.19M | 4.12M | 7.37M | -3.38M | 5.97M | 4.14M | 3.15M | 2.61M | 2.83M | 3.77M | 6.63M | 418.86K |
| Debt Issued (Net) | 0 | 0 | 0 | 5.5M | 6.15M | 5.9M | -4.47M | 2.34M | 0 | 3.95M | 7.03M | 1.59M |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | -1.58M | 230.42K | 451.43K | 0 | 0 | 0 | -490K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -1.58M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 7.19M | 4.12M | 7.37M | -8.88M | -178K | -177K | 7.38M | -180.4K | 2.83M | -185K | -374.02K | -679.39K |
| Net Change in Cash | -52.95M | 44.8M | -9.28M | -66.83M | 2.94M | 29.68M | -21.67M | 24.74M | -9.75M | -39.1M | -7.33M | -13.27M |
| Free Cash Flow | -37.35M | -44.59M | -61.52M | -45.77M | -22.19M | -23.63M | -47.58M | -49.26M | -65.85M | -34.04M | -20.44M | -7.53M |
| FCF Margin % | -449.24% | -99.4% | -687.01% | -267.91% | -523.97% | -467.92% | -731.24% | -672.62% | -661.52% | -370.87% | -309.7% | -74.91% |
| FCF Growth % | -68.34% | -88.68% | -29.3% | 7.08% | 66.3% | 30.59% | -132.82% | -553.91% | -11.52% | -283.2% | 85.33% | -103.13% |
| FCF per Share | -0.12 | -0.15 | -0.21 | -0.15 | -0.07 | -0.08 | -0.16 | -0.17 | -0.22 | -0.12 | -0.07 | -0.03 |
| FCF Conversion (FCF/Net Income) | 0.78x | 3.88x | 0.92x | 0.93x | 0.25x | 0.23x | 0.57x | 0.80x | 1.03x | 0.42x | 0.00x | -0.65x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |